Global mRNA Vaccine Core Enzyme Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 115
Published Date: 12 Mar 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development. mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs.
According to our (Global Info Research) latest study, the global mRNA Vaccine Core Enzyme market size was valued at US$ 2469 million in 2023 and is forecast to a readjusted size of USD 1782 million by 2030 with a CAGR of -2.4% during review period.
The core manufacturers of mRNA Vaccine Core Enzyme mainly include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, etc. The top four companies in the industry account for about 49% of the market. North America is the largest market, accounting for about 38% of the global market share. In terms of product type, Capping Enzyme have the largest market share of about 25%. From an application perspective, Biopharmaceutical Companies account for the largest share at around 84%.
This report is a detailed and comprehensive analysis for global mRNA Vaccine Core Enzyme market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Enzyme Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global mRNA Vaccine Core Enzyme market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global mRNA Vaccine Core Enzyme market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global mRNA Vaccine Core Enzyme market size and forecasts, by Enzyme Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global mRNA Vaccine Core Enzyme market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Vaccine Core Enzyme
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Vaccine Core Enzyme market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, Qiagen N.V., Promega, Roche CustomBiotech, Takara Bio Inc., Novoprotein, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
mRNA Vaccine Core Enzyme market is split by Enzyme Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Enzyme Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Enzyme Type
Capping Enzyme
2'-O-Methyltransferase
Inorganic Pyrophosphatase
Poly (A) Polymerase
Rnase Inhibitor
RNA Polymerase
Restriction Enzyme
Dnase I
Others
Market segment by Application
Biopharmaceutical Companies
Academic and Research Institutions
Major players covered
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe mRNA Vaccine Core Enzyme product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA Vaccine Core Enzyme, with price, sales quantity, revenue, and global market share of mRNA Vaccine Core Enzyme from 2019 to 2024.
Chapter 3, the mRNA Vaccine Core Enzyme competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Vaccine Core Enzyme breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Enzyme Type and by Application, with sales market share and growth rate by Enzyme Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and mRNA Vaccine Core Enzyme market forecast, by regions, by Enzyme Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Vaccine Core Enzyme.
Chapter 14 and 15, to describe mRNA Vaccine Core Enzyme sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Enzyme Type
1.3.1 Overview: Global mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type: 2019 Versus 2023 Versus 2030
1.3.2 Capping Enzyme
1.3.3 2'-O-Methyltransferase
1.3.4 Inorganic Pyrophosphatase
1.3.5 Poly (A) Polymerase
1.3.6 Rnase Inhibitor
1.3.7 RNA Polymerase
1.3.8 Restriction Enzyme
1.3.9 Dnase I
1.3.10 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global mRNA Vaccine Core Enzyme Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Biopharmaceutical Companies
1.4.3 Academic and Research Institutions
1.5 Global mRNA Vaccine Core Enzyme Market Size & Forecast
1.5.1 Global mRNA Vaccine Core Enzyme Consumption Value (2019 & 2023 & 2030)
1.5.2 Global mRNA Vaccine Core Enzyme Sales Quantity (2019-2030)
1.5.3 Global mRNA Vaccine Core Enzyme Average Price (2019-2030)
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher mRNA Vaccine Core Enzyme Product and Services
2.1.4 Thermo Fisher mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Thermo Fisher Recent Developments/Updates
2.2 NEB
2.2.1 NEB Details
2.2.2 NEB Major Business
2.2.3 NEB mRNA Vaccine Core Enzyme Product and Services
2.2.4 NEB mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 NEB Recent Developments/Updates
2.3 TriLink Bio Technologies
2.3.1 TriLink Bio Technologies Details
2.3.2 TriLink Bio Technologies Major Business
2.3.3 TriLink Bio Technologies mRNA Vaccine Core Enzyme Product and Services
2.3.4 TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 TriLink Bio Technologies Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck mRNA Vaccine Core Enzyme Product and Services
2.4.4 Merck mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck Recent Developments/Updates
2.5 Aldevron
2.5.1 Aldevron Details
2.5.2 Aldevron Major Business
2.5.3 Aldevron mRNA Vaccine Core Enzyme Product and Services
2.5.4 Aldevron mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Aldevron Recent Developments/Updates
2.6 Qiagen N.V.
2.6.1 Qiagen N.V. Details
2.6.2 Qiagen N.V. Major Business
2.6.3 Qiagen N.V. mRNA Vaccine Core Enzyme Product and Services
2.6.4 Qiagen N.V. mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Qiagen N.V. Recent Developments/Updates
2.7 Promega
2.7.1 Promega Details
2.7.2 Promega Major Business
2.7.3 Promega mRNA Vaccine Core Enzyme Product and Services
2.7.4 Promega mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Promega Recent Developments/Updates
2.8 Roche CustomBiotech
2.8.1 Roche CustomBiotech Details
2.8.2 Roche CustomBiotech Major Business
2.8.3 Roche CustomBiotech mRNA Vaccine Core Enzyme Product and Services
2.8.4 Roche CustomBiotech mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Roche CustomBiotech Recent Developments/Updates
2.9 Takara Bio Inc.
2.9.1 Takara Bio Inc. Details
2.9.2 Takara Bio Inc. Major Business
2.9.3 Takara Bio Inc. mRNA Vaccine Core Enzyme Product and Services
2.9.4 Takara Bio Inc. mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Takara Bio Inc. Recent Developments/Updates
2.10 Novoprotein
2.10.1 Novoprotein Details
2.10.2 Novoprotein Major Business
2.10.3 Novoprotein mRNA Vaccine Core Enzyme Product and Services
2.10.4 Novoprotein mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Novoprotein Recent Developments/Updates
2.11 Vazyme
2.11.1 Vazyme Details
2.11.2 Vazyme Major Business
2.11.3 Vazyme mRNA Vaccine Core Enzyme Product and Services
2.11.4 Vazyme mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Vazyme Recent Developments/Updates
2.12 Hongene Biotech Corporatio
2.12.1 Hongene Biotech Corporatio Details
2.12.2 Hongene Biotech Corporatio Major Business
2.12.3 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product and Services
2.12.4 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Hongene Biotech Corporatio Recent Developments/Updates
2.13 Yeasen Biotechnology
2.13.1 Yeasen Biotechnology Details
2.13.2 Yeasen Biotechnology Major Business
2.13.3 Yeasen Biotechnology mRNA Vaccine Core Enzyme Product and Services
2.13.4 Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Yeasen Biotechnology Recent Developments/Updates
3.1 Global mRNA Vaccine Core Enzyme Sales Quantity by Manufacturer (2019-2024)
3.2 Global mRNA Vaccine Core Enzyme Revenue by Manufacturer (2019-2024)
3.3 Global mRNA Vaccine Core Enzyme Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of mRNA Vaccine Core Enzyme by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 mRNA Vaccine Core Enzyme Manufacturer Market Share in 2023
3.4.3 Top 6 mRNA Vaccine Core Enzyme Manufacturer Market Share in 2023
3.5 mRNA Vaccine Core Enzyme Market: Overall Company Footprint Analysis
3.5.1 mRNA Vaccine Core Enzyme Market: Region Footprint
3.5.2 mRNA Vaccine Core Enzyme Market: Company Product Type Footprint
3.5.3 mRNA Vaccine Core Enzyme Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global mRNA Vaccine Core Enzyme Market Size by Region
4.1.1 Global mRNA Vaccine Core Enzyme Sales Quantity by Region (2019-2030)
4.1.2 Global mRNA Vaccine Core Enzyme Consumption Value by Region (2019-2030)
4.1.3 Global mRNA Vaccine Core Enzyme Average Price by Region (2019-2030)
4.2 North America mRNA Vaccine Core Enzyme Consumption Value (2019-2030)
4.3 Europe mRNA Vaccine Core Enzyme Consumption Value (2019-2030)
4.4 Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value (2019-2030)
4.5 South America mRNA Vaccine Core Enzyme Consumption Value (2019-2030)
4.6 Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value (2019-2030)
5.1 Global mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2019-2030)
5.2 Global mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2019-2030)
5.3 Global mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2019-2030)
6.1 Global mRNA Vaccine Core Enzyme Sales Quantity by Application (2019-2030)
6.2 Global mRNA Vaccine Core Enzyme Consumption Value by Application (2019-2030)
6.3 Global mRNA Vaccine Core Enzyme Average Price by Application (2019-2030)
7.1 North America mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2019-2030)
7.2 North America mRNA Vaccine Core Enzyme Sales Quantity by Application (2019-2030)
7.3 North America mRNA Vaccine Core Enzyme Market Size by Country
7.3.1 North America mRNA Vaccine Core Enzyme Sales Quantity by Country (2019-2030)
7.3.2 North America mRNA Vaccine Core Enzyme Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2019-2030)
8.2 Europe mRNA Vaccine Core Enzyme Sales Quantity by Application (2019-2030)
8.3 Europe mRNA Vaccine Core Enzyme Market Size by Country
8.3.1 Europe mRNA Vaccine Core Enzyme Sales Quantity by Country (2019-2030)
8.3.2 Europe mRNA Vaccine Core Enzyme Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2019-2030)
9.2 Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific mRNA Vaccine Core Enzyme Market Size by Region
9.3.1 Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2019-2030)
10.2 South America mRNA Vaccine Core Enzyme Sales Quantity by Application (2019-2030)
10.3 South America mRNA Vaccine Core Enzyme Market Size by Country
10.3.1 South America mRNA Vaccine Core Enzyme Sales Quantity by Country (2019-2030)
10.3.2 South America mRNA Vaccine Core Enzyme Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2019-2030)
11.2 Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa mRNA Vaccine Core Enzyme Market Size by Country
11.3.1 Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 mRNA Vaccine Core Enzyme Market Drivers
12.2 mRNA Vaccine Core Enzyme Market Restraints
12.3 mRNA Vaccine Core Enzyme Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of mRNA Vaccine Core Enzyme and Key Manufacturers
13.2 Manufacturing Costs Percentage of mRNA Vaccine Core Enzyme
13.3 mRNA Vaccine Core Enzyme Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 mRNA Vaccine Core Enzyme Typical Distributors
14.3 mRNA Vaccine Core Enzyme Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global mRNA Vaccine Core Enzyme Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 4. Thermo Fisher Major Business
Table 5. Thermo Fisher mRNA Vaccine Core Enzyme Product and Services
Table 6. Thermo Fisher mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Thermo Fisher Recent Developments/Updates
Table 8. NEB Basic Information, Manufacturing Base and Competitors
Table 9. NEB Major Business
Table 10. NEB mRNA Vaccine Core Enzyme Product and Services
Table 11. NEB mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. NEB Recent Developments/Updates
Table 13. TriLink Bio Technologies Basic Information, Manufacturing Base and Competitors
Table 14. TriLink Bio Technologies Major Business
Table 15. TriLink Bio Technologies mRNA Vaccine Core Enzyme Product and Services
Table 16. TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. TriLink Bio Technologies Recent Developments/Updates
Table 18. Merck Basic Information, Manufacturing Base and Competitors
Table 19. Merck Major Business
Table 20. Merck mRNA Vaccine Core Enzyme Product and Services
Table 21. Merck mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Merck Recent Developments/Updates
Table 23. Aldevron Basic Information, Manufacturing Base and Competitors
Table 24. Aldevron Major Business
Table 25. Aldevron mRNA Vaccine Core Enzyme Product and Services
Table 26. Aldevron mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Aldevron Recent Developments/Updates
Table 28. Qiagen N.V. Basic Information, Manufacturing Base and Competitors
Table 29. Qiagen N.V. Major Business
Table 30. Qiagen N.V. mRNA Vaccine Core Enzyme Product and Services
Table 31. Qiagen N.V. mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Qiagen N.V. Recent Developments/Updates
Table 33. Promega Basic Information, Manufacturing Base and Competitors
Table 34. Promega Major Business
Table 35. Promega mRNA Vaccine Core Enzyme Product and Services
Table 36. Promega mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Promega Recent Developments/Updates
Table 38. Roche CustomBiotech Basic Information, Manufacturing Base and Competitors
Table 39. Roche CustomBiotech Major Business
Table 40. Roche CustomBiotech mRNA Vaccine Core Enzyme Product and Services
Table 41. Roche CustomBiotech mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Roche CustomBiotech Recent Developments/Updates
Table 43. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Takara Bio Inc. Major Business
Table 45. Takara Bio Inc. mRNA Vaccine Core Enzyme Product and Services
Table 46. Takara Bio Inc. mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Takara Bio Inc. Recent Developments/Updates
Table 48. Novoprotein Basic Information, Manufacturing Base and Competitors
Table 49. Novoprotein Major Business
Table 50. Novoprotein mRNA Vaccine Core Enzyme Product and Services
Table 51. Novoprotein mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Novoprotein Recent Developments/Updates
Table 53. Vazyme Basic Information, Manufacturing Base and Competitors
Table 54. Vazyme Major Business
Table 55. Vazyme mRNA Vaccine Core Enzyme Product and Services
Table 56. Vazyme mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Vazyme Recent Developments/Updates
Table 58. Hongene Biotech Corporatio Basic Information, Manufacturing Base and Competitors
Table 59. Hongene Biotech Corporatio Major Business
Table 60. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product and Services
Table 61. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Hongene Biotech Corporatio Recent Developments/Updates
Table 63. Yeasen Biotechnology Basic Information, Manufacturing Base and Competitors
Table 64. Yeasen Biotechnology Major Business
Table 65. Yeasen Biotechnology mRNA Vaccine Core Enzyme Product and Services
Table 66. Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Yeasen Biotechnology Recent Developments/Updates
Table 68. Global mRNA Vaccine Core Enzyme Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 69. Global mRNA Vaccine Core Enzyme Revenue by Manufacturer (2019-2024) & (USD Million)
Table 70. Global mRNA Vaccine Core Enzyme Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 71. Market Position of Manufacturers in mRNA Vaccine Core Enzyme, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 72. Head Office and mRNA Vaccine Core Enzyme Production Site of Key Manufacturer
Table 73. mRNA Vaccine Core Enzyme Market: Company Product Type Footprint
Table 74. mRNA Vaccine Core Enzyme Market: Company Product Application Footprint
Table 75. mRNA Vaccine Core Enzyme New Market Entrants and Barriers to Market Entry
Table 76. mRNA Vaccine Core Enzyme Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global mRNA Vaccine Core Enzyme Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 78. Global mRNA Vaccine Core Enzyme Sales Quantity by Region (2019-2024) & (K Units)
Table 79. Global mRNA Vaccine Core Enzyme Sales Quantity by Region (2025-2030) & (K Units)
Table 80. Global mRNA Vaccine Core Enzyme Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Global mRNA Vaccine Core Enzyme Consumption Value by Region (2025-2030) & (USD Million)
Table 82. Global mRNA Vaccine Core Enzyme Average Price by Region (2019-2024) & (US$/Unit)
Table 83. Global mRNA Vaccine Core Enzyme Average Price by Region (2025-2030) & (US$/Unit)
Table 84. Global mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2019-2024) & (K Units)
Table 85. Global mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2025-2030) & (K Units)
Table 86. Global mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2019-2024) & (USD Million)
Table 87. Global mRNA Vaccine Core Enzyme Consumption Value by Enzyme Type (2025-2030) & (USD Million)
Table 88. Global mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2019-2024) & (US$/Unit)
Table 89. Global mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2025-2030) & (US$/Unit)
Table 90. Global mRNA Vaccine Core Enzyme Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Global mRNA Vaccine Core Enzyme Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Global mRNA Vaccine Core Enzyme Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Global mRNA Vaccine Core Enzyme Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Global mRNA Vaccine Core Enzyme Average Price by Application (2019-2024) & (US$/Unit)
Table 95. Global mRNA Vaccine Core Enzyme Average Price by Application (2025-2030) & (US$/Unit)
Table 96. North America mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2019-2024) & (K Units)
Table 97. North America mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2025-2030) & (K Units)
Table 98. North America mRNA Vaccine Core Enzyme Sales Quantity by Application (2019-2024) & (K Units)
Table 99. North America mRNA Vaccine Core Enzyme Sales Quantity by Application (2025-2030) & (K Units)
Table 100. North America mRNA Vaccine Core Enzyme Sales Quantity by Country (2019-2024) & (K Units)
Table 101. North America mRNA Vaccine Core Enzyme Sales Quantity by Country (2025-2030) & (K Units)
Table 102. North America mRNA Vaccine Core Enzyme Consumption Value by Country (2019-2024) & (USD Million)
Table 103. North America mRNA Vaccine Core Enzyme Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Europe mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2019-2024) & (K Units)
Table 105. Europe mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2025-2030) & (K Units)
Table 106. Europe mRNA Vaccine Core Enzyme Sales Quantity by Application (2019-2024) & (K Units)
Table 107. Europe mRNA Vaccine Core Enzyme Sales Quantity by Application (2025-2030) & (K Units)
Table 108. Europe mRNA Vaccine Core Enzyme Sales Quantity by Country (2019-2024) & (K Units)
Table 109. Europe mRNA Vaccine Core Enzyme Sales Quantity by Country (2025-2030) & (K Units)
Table 110. Europe mRNA Vaccine Core Enzyme Consumption Value by Country (2019-2024) & (USD Million)
Table 111. Europe mRNA Vaccine Core Enzyme Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2019-2024) & (K Units)
Table 113. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2025-2030) & (K Units)
Table 114. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value by Region (2025-2030) & (USD Million)
Table 120. South America mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2019-2024) & (K Units)
Table 121. South America mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2025-2030) & (K Units)
Table 122. South America mRNA Vaccine Core Enzyme Sales Quantity by Application (2019-2024) & (K Units)
Table 123. South America mRNA Vaccine Core Enzyme Sales Quantity by Application (2025-2030) & (K Units)
Table 124. South America mRNA Vaccine Core Enzyme Sales Quantity by Country (2019-2024) & (K Units)
Table 125. South America mRNA Vaccine Core Enzyme Sales Quantity by Country (2025-2030) & (K Units)
Table 126. South America mRNA Vaccine Core Enzyme Consumption Value by Country (2019-2024) & (USD Million)
Table 127. South America mRNA Vaccine Core Enzyme Consumption Value by Country (2025-2030) & (USD Million)
Table 128. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2019-2024) & (K Units)
Table 129. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Enzyme Type (2025-2030) & (K Units)
Table 130. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Application (2019-2024) & (K Units)
Table 131. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Application (2025-2030) & (K Units)
Table 132. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Country (2019-2024) & (K Units)
Table 133. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity by Country (2025-2030) & (K Units)
Table 134. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Country (2019-2024) & (USD Million)
Table 135. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value by Country (2025-2030) & (USD Million)
Table 136. mRNA Vaccine Core Enzyme Raw Material
Table 137. Key Manufacturers of mRNA Vaccine Core Enzyme Raw Materials
Table 138. mRNA Vaccine Core Enzyme Typical Distributors
Table 139. mRNA Vaccine Core Enzyme Typical Customers
List of Figures
Figure 1. mRNA Vaccine Core Enzyme Picture
Figure 2. Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type in 2023
Figure 4. Capping Enzyme Examples
Figure 5. 2'-O-Methyltransferase Examples
Figure 6. Inorganic Pyrophosphatase Examples
Figure 7. Poly (A) Polymerase Examples
Figure 8. Rnase Inhibitor Examples
Figure 9. RNA Polymerase Examples
Figure 10. Restriction Enzyme Examples
Figure 11. Dnase I Examples
Figure 12. Restriction Enzyme Examples
Figure 13. Global mRNA Vaccine Core Enzyme Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 14. Global mRNA Vaccine Core Enzyme Revenue Market Share by Application in 2023
Figure 15. Biopharmaceutical Companies Examples
Figure 16. Academic and Research Institutions Examples
Figure 17. Global mRNA Vaccine Core Enzyme Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global mRNA Vaccine Core Enzyme Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global mRNA Vaccine Core Enzyme Sales Quantity (2019-2030) & (K Units)
Figure 20. Global mRNA Vaccine Core Enzyme Price (2019-2030) & (US$/Unit)
Figure 21. Global mRNA Vaccine Core Enzyme Sales Quantity Market Share by Manufacturer in 2023
Figure 22. Global mRNA Vaccine Core Enzyme Revenue Market Share by Manufacturer in 2023
Figure 23. Producer Shipments of mRNA Vaccine Core Enzyme by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 24. Top 3 mRNA Vaccine Core Enzyme Manufacturer (Revenue) Market Share in 2023
Figure 25. Top 6 mRNA Vaccine Core Enzyme Manufacturer (Revenue) Market Share in 2023
Figure 26. Global mRNA Vaccine Core Enzyme Sales Quantity Market Share by Region (2019-2030)
Figure 27. Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Region (2019-2030)
Figure 28. North America mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 29. Europe mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 30. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 31. South America mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 32. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 33. Global mRNA Vaccine Core Enzyme Sales Quantity Market Share by Enzyme Type (2019-2030)
Figure 34. Global mRNA Vaccine Core Enzyme Consumption Value Market Share by Enzyme Type (2019-2030)
Figure 35. Global mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2019-2030) & (US$/Unit)
Figure 36. Global mRNA Vaccine Core Enzyme Sales Quantity Market Share by Application (2019-2030)
Figure 37. Global mRNA Vaccine Core Enzyme Revenue Market Share by Application (2019-2030)
Figure 38. Global mRNA Vaccine Core Enzyme Average Price by Application (2019-2030) & (US$/Unit)
Figure 39. North America mRNA Vaccine Core Enzyme Sales Quantity Market Share by Enzyme Type (2019-2030)
Figure 40. North America mRNA Vaccine Core Enzyme Sales Quantity Market Share by Application (2019-2030)
Figure 41. North America mRNA Vaccine Core Enzyme Sales Quantity Market Share by Country (2019-2030)
Figure 42. North America mRNA Vaccine Core Enzyme Consumption Value Market Share by Country (2019-2030)
Figure 43. United States mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 44. Canada mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 45. Mexico mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 46. Europe mRNA Vaccine Core Enzyme Sales Quantity Market Share by Enzyme Type (2019-2030)
Figure 47. Europe mRNA Vaccine Core Enzyme Sales Quantity Market Share by Application (2019-2030)
Figure 48. Europe mRNA Vaccine Core Enzyme Sales Quantity Market Share by Country (2019-2030)
Figure 49. Europe mRNA Vaccine Core Enzyme Consumption Value Market Share by Country (2019-2030)
Figure 50. Germany mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 51. France mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 52. United Kingdom mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 53. Russia mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 54. Italy mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 55. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity Market Share by Enzyme Type (2019-2030)
Figure 56. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity Market Share by Application (2019-2030)
Figure 57. Asia-Pacific mRNA Vaccine Core Enzyme Sales Quantity Market Share by Region (2019-2030)
Figure 58. Asia-Pacific mRNA Vaccine Core Enzyme Consumption Value Market Share by Region (2019-2030)
Figure 59. China mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 60. Japan mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 61. South Korea mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 62. India mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 63. Southeast Asia mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 64. Australia mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 65. South America mRNA Vaccine Core Enzyme Sales Quantity Market Share by Enzyme Type (2019-2030)
Figure 66. South America mRNA Vaccine Core Enzyme Sales Quantity Market Share by Application (2019-2030)
Figure 67. South America mRNA Vaccine Core Enzyme Sales Quantity Market Share by Country (2019-2030)
Figure 68. South America mRNA Vaccine Core Enzyme Consumption Value Market Share by Country (2019-2030)
Figure 69. Brazil mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 70. Argentina mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 71. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity Market Share by Enzyme Type (2019-2030)
Figure 72. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity Market Share by Application (2019-2030)
Figure 73. Middle East & Africa mRNA Vaccine Core Enzyme Sales Quantity Market Share by Country (2019-2030)
Figure 74. Middle East & Africa mRNA Vaccine Core Enzyme Consumption Value Market Share by Country (2019-2030)
Figure 75. Turkey mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 76. Egypt mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 77. Saudi Arabia mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 78. South Africa mRNA Vaccine Core Enzyme Consumption Value (2019-2030) & (USD Million)
Figure 79. mRNA Vaccine Core Enzyme Market Drivers
Figure 80. mRNA Vaccine Core Enzyme Market Restraints
Figure 81. mRNA Vaccine Core Enzyme Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of mRNA Vaccine Core Enzyme in 2023
Figure 84. Manufacturing Process Analysis of mRNA Vaccine Core Enzyme
Figure 85. mRNA Vaccine Core Enzyme Industrial Chain
Figure 86. Sales Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Thermo Fisher NEB TriLink Bio Technologies Merck Aldevron Qiagen N.V. Promega Roche CustomBiotech Takara Bio Inc. Novoprotein Vazyme Hongene Biotech Corporatio Yeasen Biotechnology
Related Reports
03 Apr 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
